Skip to main content

CORRECTION article

Front. Immunol., 14 May 2018
Sec. Cancer Immunity and Immunotherapy
This article is part of the Research Topic Neoantigens Generated by Individual Mutations and Their Role in Immunity and Immunotherapy View all 11 articles

Corrigendum: An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes

  • 1Department of Bio and Health Informatics, Technical University of Denmark, Kongens Lyngby, Denmark
  • 2Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín, Buenos Aires, Argentina
  • 3Section for Immunology and Vaccinology, National Veterinary Institute, Technical University of Denmark, Kongens Lyngby, Denmark
  • 4Computational Health Informatics Program (CHIP), Boston Children’s Hospital, Harvard Medical School, Boston, MA, United States

A corrigendum on

An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes
by Bjerregaard A-M, Nielsen M, Jurtz V, Barra CM, Hadrup SR, Szallasi Z, et al. Front Immunol (2017) 8:1566. doi:10.3389/fimmu.2017.01566

An outdated version of Supplementary Table 1 was uploaded to the final version of the paper for publication. This table has not been under peer review and does not include the information described in the paper such as the similarity measurement column. The correct Supplementary Table 1 has now been published in the original article. The authors apologize for this oversight. This error does not change the scientific conclusion of the article in any way.

The original article has been updated.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: neoepitopes, neoantigens, prediction, immunogenicity, mutations, MHC binding

Citation: Bjerregaard A-M, Nielsen M, Jurtz V, Barra CM, Hadrup SR, Szallasi Z and Eklund AC (2018) Corrigendum: An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes. Front. Immunol. 9:1007. doi: 10.3389/fimmu.2018.01007

Received: 26 March 2018; Accepted: 23 April 2018;
Published: 14 May 2018

Edited and Reviewed by: Mustafa Diken, Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Germany

Copyright: © 2018 Bjerregaard, Nielsen, Jurtz, Barra, Hadrup, Szallasi and Eklund. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Anne-Mette Bjerregaard, ambj@bioinformatics.dtu.dk;
Aron Charles Eklund, eklund@bioinformatics.dtu.dk

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.